权威 · 专业 · 易懂

您的血液健康专属指南

聚合全球前沿的血液病诊疗、研究和科普信息，为广大血液病患者、家属以及关注血液健康的人士提供权威、全面、易懂的一站式参考平台。

开始阅读常见问题

科普文章

血液病基础知识与健康科普

浏览文章

患者空间

关怀指导与康复经验分享

浏览文章

常见问题

血液病热门问题专业解答

查看FAQ

7+

专业文章

3

内容分类

10+

疾病话题

100%

免费阅读

最新文章

查看全部文章 »

血液病科普知识、最新研究进展与患者关怀

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study

Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-02993-4Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party s

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib

Leukemia, Published online: 11 June 2026; doi:10.1038/s41375-026-03002-4Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and ni

Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analysis

Leukemia, Published online: 10 June 2026; doi:10.1038/s41375-026-02987-2Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analy

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report

Leukemia, Published online: 10 June 2026; doi:10.1038/s41375-026-02990-7Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report

FAQ